img

Global Cell-Free Fetal DNA Testing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Cell-Free Fetal DNA Testing Market Research Report 2024

Cell-free DNA screening is a test that can determine if a woman has a higher chance of having a fetus with Down syndrome (trisomy 21), trisomy 18, trisomy 13 or an abnormality in the sex chromosomes (X and Y chromosomes). With this test, a sample of the woman's blood is taken after 10 weeks of pregnancy.
According to MRAResearch’s new survey, global Cell-Free Fetal DNA Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Key companies engaged in the Cell-Free Fetal DNA Testing industry include Roche, Arup Laboratories, PerkinElmer, Eurofins Biomnis, BGI, Berry Genomics, DAAN GENE, CapitalBio and Annoroad, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cell-Free Fetal DNA Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cell-Free Fetal DNA Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cell-Free Fetal DNA Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche
Arup Laboratories
PerkinElmer
Eurofins Biomnis
BGI
Berry Genomics
DAAN GENE
CapitalBio
Annoroad
ADICON
KingMed
Segment by Type
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity Testing
Others

Segment by Application


Hospital
Clinic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cell-Free Fetal DNA Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Abnormal Chromosome Number Detection
1.2.3 Gender Testing
1.2.4 Paternally Inherited Disorder Detection
1.2.5 Paternity Testing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cell-Free Fetal DNA Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Free Fetal DNA Testing Market Perspective (2018-2033)
2.2 Cell-Free Fetal DNA Testing Growth Trends by Region
2.2.1 Global Cell-Free Fetal DNA Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cell-Free Fetal DNA Testing Historic Market Size by Region (2018-2023)
2.2.3 Cell-Free Fetal DNA Testing Forecasted Market Size by Region (2024-2033)
2.3 Cell-Free Fetal DNA Testing Market Dynamics
2.3.1 Cell-Free Fetal DNA Testing Industry Trends
2.3.2 Cell-Free Fetal DNA Testing Market Drivers
2.3.3 Cell-Free Fetal DNA Testing Market Challenges
2.3.4 Cell-Free Fetal DNA Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Free Fetal DNA Testing Players by Revenue
3.1.1 Global Top Cell-Free Fetal DNA Testing Players by Revenue (2018-2023)
3.1.2 Global Cell-Free Fetal DNA Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cell-Free Fetal DNA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-Free Fetal DNA Testing Revenue
3.4 Global Cell-Free Fetal DNA Testing Market Concentration Ratio
3.4.1 Global Cell-Free Fetal DNA Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free Fetal DNA Testing Revenue in 2022
3.5 Cell-Free Fetal DNA Testing Key Players Head office and Area Served
3.6 Key Players Cell-Free Fetal DNA Testing Product Solution and Service
3.7 Date of Enter into Cell-Free Fetal DNA Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free Fetal DNA Testing Breakdown Data by Type
4.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Type (2018-2023)
4.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Type (2024-2033)
5 Cell-Free Fetal DNA Testing Breakdown Data by Application
5.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Application (2018-2023)
5.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cell-Free Fetal DNA Testing Market Size (2018-2033)
6.2 North America Cell-Free Fetal DNA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cell-Free Fetal DNA Testing Market Size by Country (2018-2023)
6.4 North America Cell-Free Fetal DNA Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Free Fetal DNA Testing Market Size (2018-2033)
7.2 Europe Cell-Free Fetal DNA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cell-Free Fetal DNA Testing Market Size by Country (2018-2023)
7.4 Europe Cell-Free Fetal DNA Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Free Fetal DNA Testing Market Size (2018-2033)
8.2 Asia-Pacific Cell-Free Fetal DNA Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Free Fetal DNA Testing Market Size (2018-2033)
9.2 Latin America Cell-Free Fetal DNA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cell-Free Fetal DNA Testing Market Size by Country (2018-2023)
9.4 Latin America Cell-Free Fetal DNA Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Free Fetal DNA Testing Market Size (2018-2033)
10.2 Middle East & Africa Cell-Free Fetal DNA Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Cell-Free Fetal DNA Testing Introduction
11.1.4 Roche Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Arup Laboratories
11.2.1 Arup Laboratories Company Detail
11.2.2 Arup Laboratories Business Overview
11.2.3 Arup Laboratories Cell-Free Fetal DNA Testing Introduction
11.2.4 Arup Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.2.5 Arup Laboratories Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Cell-Free Fetal DNA Testing Introduction
11.3.4 PerkinElmer Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.3.5 PerkinElmer Recent Development
11.4 Eurofins Biomnis
11.4.1 Eurofins Biomnis Company Detail
11.4.2 Eurofins Biomnis Business Overview
11.4.3 Eurofins Biomnis Cell-Free Fetal DNA Testing Introduction
11.4.4 Eurofins Biomnis Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.4.5 Eurofins Biomnis Recent Development
11.5 BGI
11.5.1 BGI Company Detail
11.5.2 BGI Business Overview
11.5.3 BGI Cell-Free Fetal DNA Testing Introduction
11.5.4 BGI Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.5.5 BGI Recent Development
11.6 Berry Genomics
11.6.1 Berry Genomics Company Detail
11.6.2 Berry Genomics Business Overview
11.6.3 Berry Genomics Cell-Free Fetal DNA Testing Introduction
11.6.4 Berry Genomics Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.6.5 Berry Genomics Recent Development
11.7 DAAN GENE
11.7.1 DAAN GENE Company Detail
11.7.2 DAAN GENE Business Overview
11.7.3 DAAN GENE Cell-Free Fetal DNA Testing Introduction
11.7.4 DAAN GENE Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.7.5 DAAN GENE Recent Development
11.8 CapitalBio
11.8.1 CapitalBio Company Detail
11.8.2 CapitalBio Business Overview
11.8.3 CapitalBio Cell-Free Fetal DNA Testing Introduction
11.8.4 CapitalBio Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.8.5 CapitalBio Recent Development
11.9 Annoroad
11.9.1 Annoroad Company Detail
11.9.2 Annoroad Business Overview
11.9.3 Annoroad Cell-Free Fetal DNA Testing Introduction
11.9.4 Annoroad Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.9.5 Annoroad Recent Development
11.10 ADICON
11.10.1 ADICON Company Detail
11.10.2 ADICON Business Overview
11.10.3 ADICON Cell-Free Fetal DNA Testing Introduction
11.10.4 ADICON Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.10.5 ADICON Recent Development
11.11 KingMed
11.11.1 KingMed Company Detail
11.11.2 KingMed Business Overview
11.11.3 KingMed Cell-Free Fetal DNA Testing Introduction
11.11.4 KingMed Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.11.5 KingMed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Abnormal Chromosome Number Detection
Table 3. Key Players of Gender Testing
Table 4. Key Players of Paternally Inherited Disorder Detection
Table 5. Key Players of Paternity Testing
Table 6. Key Players of Others
Table 7. Global Cell-Free Fetal DNA Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Cell-Free Fetal DNA Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Cell-Free Fetal DNA Testing Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cell-Free Fetal DNA Testing Market Share by Region (2018-2023)
Table 11. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Cell-Free Fetal DNA Testing Market Share by Region (2024-2033)
Table 13. Cell-Free Fetal DNA Testing Market Trends
Table 14. Cell-Free Fetal DNA Testing Market Drivers
Table 15. Cell-Free Fetal DNA Testing Market Challenges
Table 16. Cell-Free Fetal DNA Testing Market Restraints
Table 17. Global Cell-Free Fetal DNA Testing Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cell-Free Fetal DNA Testing Market Share by Players (2018-2023)
Table 19. Global Top Cell-Free Fetal DNA Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free Fetal DNA Testing as of 2022)
Table 20. Ranking of Global Top Cell-Free Fetal DNA Testing Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cell-Free Fetal DNA Testing Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell-Free Fetal DNA Testing Product Solution and Service
Table 24. Date of Enter into Cell-Free Fetal DNA Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell-Free Fetal DNA Testing Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cell-Free Fetal DNA Testing Revenue Market Share by Type (2018-2023)
Table 28. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Cell-Free Fetal DNA Testing Revenue Market Share by Type (2024-2033)
Table 30. Global Cell-Free Fetal DNA Testing Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cell-Free Fetal DNA Testing Revenue Market Share by Application (2018-2023)
Table 32. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Cell-Free Fetal DNA Testing Revenue Market Share by Application (2024-2033)
Table 34. North America Cell-Free Fetal DNA Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Cell-Free Fetal DNA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Cell-Free Fetal DNA Testing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Cell-Free Fetal DNA Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Cell-Free Fetal DNA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Cell-Free Fetal DNA Testing Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Cell-Free Fetal DNA Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Cell-Free Fetal DNA Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Cell-Free Fetal DNA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Cell-Free Fetal DNA Testing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Cell-Free Fetal DNA Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2024-2033) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Cell-Free Fetal DNA Testing Product
Table 52. Roche Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Arup Laboratories Company Detail
Table 55. Arup Laboratories Business Overview
Table 56. Arup Laboratories Cell-Free Fetal DNA Testing Product
Table 57. Arup Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 58. Arup Laboratories Recent Development
Table 59. PerkinElmer Company Detail
Table 60. PerkinElmer Business Overview
Table 61. PerkinElmer Cell-Free Fetal DNA Testing Product
Table 62. PerkinElmer Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 63. PerkinElmer Recent Development
Table 64. Eurofins Biomnis Company Detail
Table 65. Eurofins Biomnis Business Overview
Table 66. Eurofins Biomnis Cell-Free Fetal DNA Testing Product
Table 67. Eurofins Biomnis Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 68. Eurofins Biomnis Recent Development
Table 69. BGI Company Detail
Table 70. BGI Business Overview
Table 71. BGI Cell-Free Fetal DNA Testing Product
Table 72. BGI Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 73. BGI Recent Development
Table 74. Berry Genomics Company Detail
Table 75. Berry Genomics Business Overview
Table 76. Berry Genomics Cell-Free Fetal DNA Testing Product
Table 77. Berry Genomics Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 78. Berry Genomics Recent Development
Table 79. DAAN GENE Company Detail
Table 80. DAAN GENE Business Overview
Table 81. DAAN GENE Cell-Free Fetal DNA Testing Product
Table 82. DAAN GENE Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 83. DAAN GENE Recent Development
Table 84. CapitalBio Company Detail
Table 85. CapitalBio Business Overview
Table 86. CapitalBio Cell-Free Fetal DNA Testing Product
Table 87. CapitalBio Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 88. CapitalBio Recent Development
Table 89. Annoroad Company Detail
Table 90. Annoroad Business Overview
Table 91. Annoroad Cell-Free Fetal DNA Testing Product
Table 92. Annoroad Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 93. Annoroad Recent Development
Table 94. ADICON Company Detail
Table 95. ADICON Business Overview
Table 96. ADICON Cell-Free Fetal DNA Testing Product
Table 97. ADICON Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 98. ADICON Recent Development
Table 99. KingMed Company Detail
Table 100. KingMed Business Overview
Table 101. KingMed Cell-Free Fetal DNA Testing Product
Table 102. KingMed Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 103. KingMed Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Free Fetal DNA Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cell-Free Fetal DNA Testing Market Share by Type: 2022 VS 2033
Figure 3. Abnormal Chromosome Number Detection Features
Figure 4. Gender Testing Features
Figure 5. Paternally Inherited Disorder Detection Features
Figure 6. Paternity Testing Features
Figure 7. Others Features
Figure 8. Global Cell-Free Fetal DNA Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Cell-Free Fetal DNA Testing Market Share by Application: 2022 VS 2033
Figure 10. Hospital Case Studies
Figure 11. Clinic Center Case Studies
Figure 12. Cell-Free Fetal DNA Testing Report Years Considered
Figure 13. Global Cell-Free Fetal DNA Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Cell-Free Fetal DNA Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Cell-Free Fetal DNA Testing Market Share by Region: 2022 VS 2033
Figure 16. Global Cell-Free Fetal DNA Testing Market Share by Players in 2022
Figure 17. Global Top Cell-Free Fetal DNA Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free Fetal DNA Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cell-Free Fetal DNA Testing Revenue in 2022
Figure 19. North America Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Cell-Free Fetal DNA Testing Market Share by Country (2018-2033)
Figure 21. United States Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Cell-Free Fetal DNA Testing Market Share by Country (2018-2033)
Figure 25. Germany Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Cell-Free Fetal DNA Testing Market Share by Region (2018-2033)
Figure 33. China Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Cell-Free Fetal DNA Testing Market Share by Country (2018-2033)
Figure 41. Mexico Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Cell-Free Fetal DNA Testing Market Share by Country (2018-2033)
Figure 45. Turkey Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Roche Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 48. Arup Laboratories Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 49. PerkinElmer Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 50. Eurofins Biomnis Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 51. BGI Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 52. Berry Genomics Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 53. DAAN GENE Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 54. CapitalBio Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 55. Annoroad Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 56. ADICON Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 57. KingMed Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed